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Streptococcus suis (S. suis) is a Gram-positive bacterium with clinical 
relevance in pigs and is emerging in human. Based on differences in antigenic 
properties of the polysaccharide capsule, 35 S. suis serotypes have been 
distinguished to date, of which serotype 2 is most commonly associated with 
disease in human and pigs, worldwide. Recently, S. suis emerged as a zoonotic 
agent in human in contact with infected pigs or with their products(Wertheim et al. 
2009)(Wertheim et al. 2009)(Wertheim et al. 2009)(Wertheim et al. 2009). In 2006 
a major S. suis outbreak resulted in more than 200 human cases with a fatality rate 
of nearly 20% in China. More recently, several studies from Thailand, Hong Kong, 
Taiwan, Singapore and Viet Nam demonstrated that S. suis can cause adult 
endocarditis, septicemia, arthritis and especially meningitis with high fatality rate 
and severe neurological sequelae. Multilocus enzyme electrophoresis, restriction 
endonuclease analysis with HaeIII, ribotyping, repetitive extragenic palindromic 
(REP) or enterobacterial repetitive intergenic consensus (ERIC), arbitrarily primed 
PCR, and pulsed-field gel electrophoresis (PFGE) have been used to determine S. 
suis strains epidemiological relationships. Characterization of the 16S-23S 
ribosomal (r) DNA intergenic spacer region (ITS) has also been used to compare 
bacterial strains and to identify species within the genus Streptococcus, including S. 
suis. 
In this study, a specific and sensitive PCR assay for fast detection of S. suis 
serotype 2 is crucial to meningitis treatment based on the S. suis serotype 2 cps2J 
gene was developed and evaluated for diagnosis in meningitis patients hospitalized 
in Thua Thien Hue, Viet Nam. The intergenic spacer region was amplified by 
traditional PCR from strains obtained in this study and sequenced. ITS - based 
phylogenetic analysis is also presented and discussed. We also identified and 
characterized the main immunodominant antigens of Streptococcus suis serotype 2 
based on the immunoproteomics approach. 
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2.1. Streptococcus suis: taxonomy and main biological features 
In the early 1950s, Jensen et al. (1951) and Field et al. (1954) reported 
streptococcal septicemia as cause of meningitis and arthritis in pigs and piglets in 
the United Kingdom and in the Netherlands. Later, de Moor el al. (1963) described 
similar hemolytic streptococci that had been isolated from septicemic pigs and 
could be differentiated biochemically and serologically from the known 
streptococcal species. These streptococci were placed into two Lancefield groups. 
Strains isolated in newborn pigs were designated “group S”, whereas strains from 
older pigs were designated “group R” (Staats et al. 1997). 
There were reports indicating that some strains of this species contained 
streptococcal group D antigens. However, later reports indicate that group R and 
group D antigens are similar but not identical, and observed reaction with group D 
antisera was due to cross-reaction. S. suis is a very heterogeneous species. So far, 35 
capsular serotypes (types 1 to 34 and type 1/2) have been identified based on the 
difference of antigenic carbohydrate types of their capsule (Staats et al. 1997). The 
discovery of additional serotypes of this species led to a change in nomenclature 
used to indicate capsular types. Group R, the most common strain identified, is type 
2, and group S is type 1. The important change to clinical microbiologists is that the 
only serotype identified from human has been type 2 (group R). There are 
difficulties when using the original method for serological grouping of S. suis with 
Lancefield procedure. Therefore, it is recommended that a capsular reaction should 
be used for identification of the various serotypes. This reaction is similar to the 
quelling reaction used to type S. pneumoniae. A modified Lancefield extraction 
used to identify type 2 by using group-precipitating antiserum. (Gottschalk et al. 
1991, Staats et al. 1997, Facklam 2002). 
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Table 1. Binomial nomenclature of Streptococcus suis (NCBI taxonomy ID: 1307)  
Binomial name 
Streptococcus suis 
(ex Elliot 1966) 
Kilpper-Bälz & Schleifer 1987 
Scientific classification  
Kingdom: Bacteria  
Phylum: Firmicutes 
Class: Bacilli  
Order: Lactobacillales  
Family: Streptococcaceae  
Genus: Streptococcus  
Species: S. suis 
 
Streptococcus suis is a Gram-positive facultative anaerobe that belongs to 
Lancefield groups R and S. It is α- or β-hemolytic on sheep or horse blood agar, 
respectively. The organism is coccoid, ovoid, and occurs singly, in pairs or short 
chains (Fig. 1). 
 
       
Figure 1. Gram-positive cocci (Streptococcus suis), single or in pairs, visible in Gram stain 
(original magnification, ×100; left).  Scanning electron micrograph (SEM) graphic of 
Streptococcus suis (right) 
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Streptococcus suis is one of the most important pathogens impacting the 
swine industry worldwide as it is responsible for important economic losses. It 
causes a wide variety of signs in pigs, including meningitis, septicemia and 
endocarditis. Among the 35 serotypes originally described based on capsular 
polysaccharide (CPS) antigens, serotype 2 is not only prevalent in swine diseases, 
but is also considered to be an emerging zoonotic agent causing meningitis and 
streptococcal toxic shock-like syndrome (STSLS) in human (Gottschalk et al. 
2010). Nowadays, S. suis has gained more attention since recent recognition of its 
high prevalence in human meningitis cases in south-east and east Asia, and reports 
of outbreaks that resulted in high mortality rates (Wangkaew et al. 2006, Yang et al. 
2006, Wangsomboonsiri et al. 2008, Wertheim et al. 2009, Tsai et al. 2012). 
 
       
Figure 2. Gram-positive cocci (Streptococcus suis), single or in pairs, visible in direct 
Gram stain of a CSF sample (original magnification, ×100; left). Growth of S. suis colonies 
on blood agar with optochin disk (right). (Wertheim et al. 2009) 
 
2.2. Streptococcus suis serotype 2 and meningitis  
The most serious form of meningitis is acute bacterial meningitis. Even when 
treated, bacterial meningitis can be fatal in severe cases. Indeed if bacterial 
meningitis progresses rapidly, in 24 hours or less, death may occur in more than 
half of those who develop it, even with proper medical treatment  (CDC 2015). 
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S. suis is a swine pathogen and a zoonotic agent afflicting people in close 
contact with infected pigs or pork meat. Although sporadic cases of human 
infections have been reported worldwide during the last 45 years, deadly S. suis 
outbreaks emerged in Asia (Fig 1.3).  
 
 
Figure 3. Distribution map of S. suis infection (GIDEON Informatics et al. 2015) 
 
Wangkaew et al. (2006) reported that forty-one patients (32 men and 9 
women, mean age 51 years) with S. suis infection were identified. Three patients 
had a history of exposure to pig or pork and one patient had a history of raw beef 
consumption. Clinical manifestations included infective endocarditis, meningitis, 
sepsis, spondylodiscitis, and endophthalmitis in 16, 13, 10, 1, and 1 patient, 
respectively. The overall mortality rate was 19.5%. On univariabe analysis, 
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patients, who had low serum albumin, high serum total bilirubin, low platelet, and 
rapid onset of illness were significantly correlated with high mortality rate. All 
bacterial isolates were sensitive to penicillin (mean MIC90Z0.027 mg/ml) 
(Wangkaew et al. 2006). 
An outbreak of S. suis serotype 2 occurred in villagers after direct exposure 
to deceased or sick pigs in Sichuan, China. Prohibition of slaughtering in 
backyards brought the outbreak to a halt. From June 10th to August 21st, 2005, 68 
laboratorial confirmed cases of human S. suis infections were reported. All were 
villagers who gave an evidence of direct exposure to deceased or sick pigs in their 
backyards where slaughtering was performed. Twenty-six (38%) presented with 
toxic shock syndrome of which 15 (58%) died. Other presentations were 
septicemia or meningitis. A virulent strain of this bacterium is speculated to be in 
circulation, and is responsible for the unusual presentation of toxic shock 
syndrome with high case fatality (Yang et al. 2006).  
Nguyen et al. (2012) reported that 450 patients were prospectively studied 
with suspected bacterial meningitis. In patients infected with S. suis, bacterial 
DNA load at hospital admission and during treatment was analyzed in 
cerebrospinal fluid (CFS) specimens using quantitative real-time polymerase chain 
reaction (real-time PCR). S. suis was the most common pathogen and was detected 
in 33.6% of the patients. Fifty of these 151 patients reported exposure to pigs or 
pork. Mortality was low but mild to severe hearing loss occurred in 66.4% patients 
of S.  suis infection. S. suis serotype 2 is the most frequent cause of bacterial 
meningitis in adults in southern Vietnam and is associated with substantial 




Nguyen Hoang Bach - Molecular and antigenic characterization of Streptococcus suis serotype 2 isolates in 
central Vietnam - Doctorate Thesis of International PhD School In Biomolecular and Biotechnological 




Table 2. Common causes of bacterial meningitis by age group (CDC 2015)  
Age Group Causes 
Newborns Group B Streptococcus, Escherichia coli, Listeria 
monocytogenes 
Infants and Children Streptococcus pneumoniae, Neisseria meningitidis, 
Haemophilus influenzae type b 
Adolescents and Young 
Adults 
Neisseria meningitidis, Streptococcus pneumoniae, 
Streptococcus suis  
Older Adults Streptococcus pneumoniae, Neisseria meningitidis, 
Listeria monocytogenes 
 
2.3. Invasion of Streptococcus suis 
Pigs may get infected by S. suis via both vertical and horizontal transmission. 
Bacteria can persist in the tonsils of colonized animals and may never develop 
disease (carrier animals). Conversely, some carrier piglets will eventually develop 
bacteremia, septicemia and/or meningitis due to dissemination of S. suis from 
tonsils and/or other mucosal surfaces, usually when maternal antibodies decline. To 
cause disease, bacteria must breach epithelial barriers, reach and survive in the 
bloodstream, invade different organs and cause exaggerated inflammation  (Madsen 
et al. 2002, Cloutier et al. 2003). 
Humans can get infected through skin lesions or through the oral route, 
although carriage of S. suis by human without clinical signs (usually slaughterhouse 
workers) has also been described (Gottschalk et al. 2010). Infection of human may 
also begin with colonization followed by invasion, bacteremia and septicemia with 
or without meningitis (Fittipaldi et al. 2012). 
2.3.1. Colonization: adherence and invasion of epithelial surfaces 
To date, the early mechanisms used by S. suis to colonize the host are poorly 
known. The bacteria may survive in swine tonsils for long periods of time. The 
tonsillar lymphoid tissue is overlaid by mucosal epithelium. After adhesion and 
invasion of epithelial cells in tonsils, the bacteria may escape the host immune 
systems by hiding in epithelial invaginations within the lymphoid tissue. Clinically 
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healthy pigs can carry S. suis in their nasal cavities, tonsils and upper respiratory 
tract, contributing to the dissemination of this pathogen. Although, S. suis is 
usually found in very low quantities in tonsils of clinically healthy pigs in herd, it 
might cross the first natural line of the host defense and initiate disease. This thing 
can be explained by that the S. suis breaches the mucosal epithelium in the upper 
respiratory tract of pigs (Torremorell et al. 1998, Cloutier et al. 2003, Fittipaldi et al. 
2012). 
Human may be infected by S. suis via the oral route. Upon infection, bacteria 
interact with epithelial cells either at the epidermal surface or in the intestine 
(Wertheim et al. 2009, Gottschalk et al. 2010). The bacterial adhesion and invasion 
of epithelial cells are usually associated with the first steps of colonization by 
mucosal pathogens. There are a few mechanistic studies are available regarding the 
interactions between S. suis and epithelial cells. Virulent S. suis strains can adhere 
to epithelial cells from the respiratory tract of human (Figure 4) (Norton et al. 1999, 
Lalonde et al. 2000, Benga et al. 2004). 
 
Figure 4. Interactions of Streptococcus suis with epithelial cells and extracellular 
matrix proteins (Fittipaldi et al. 2012).  
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Several factors involved in adhesion are bacterial surface proteins such as 
enolase, GAPDH, 6-PGD, AmyA, as well as a glutamine synthetase. Unidentified 
LPXTG-containing adhesins (including pili) have been suggested to participate in 
adhesion to epithelial cells. The actual contribution of these factors has not yet been 
demonstrated. 
Invasion of epithelial cells other than choroid plexus epithelial cells by 
encapsulated S. suis serotype 2 is still controversial. In the case of suilysin-positive 
strains, expression of this hemolysin may be instrumental in breaching the 
epithelium. IgA protease-producing bacteria may also take advantage of released 
Fab fragments after IgA proteolysis to enhance their surface hydrophobicity and 
thus adhesion to host cells. S. suis binds extracellular matrix proteins such as 
fibronectin, plasminogen and collagen. Enolase, a fibronectin fibrinogen binding 
protein, and a dipeptidyl peptidase IV all bind human fibronectin and fibrinogen. 
Enolase also mediates binding to plasminogen. Also necessary for bacterial-
extracellular matrix proteins interactions are LPXTG-containing proteins, since 
deletion of SrtA impairs S. suis binding to these host factors. Collagen degradation 
by means of the secretion of a putative collagenase has been proposed. Capsule 
down regulation upon the interactions could facilitate the display of adhesions 
(Fittipaldi et al. 2012). 
2.3.2. S. suis survival in blood and dissemination  
 Cell invasion or cell disruption of S. suis may lead to the first step of 
systemic disease development. It has been proposed that S. suis may gain entry to 
the systemic circulation primarily through the palatine tonsils, after adhesion and 
invasion of epithelial cells and interaction with cells of the myeloid lineage. When 
S. suis reaches deeper tissues and/or the bloodstream, it is subject to the action of 
phagocytic cells of the innate immune system. Because there are no specific 
antibodies, S. suis could be resist phagocytosis and persist in blood at high 
concentrations, with inflammatory consequences. Bacterial survival largely depends 
on the production of CPS. There were many reports of the role of CPS in survival 
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capability of S. suis, which could protect S. suis from neutrophil and 




Figure 5. Suggested mechanism of avoidance innate immune response of the host 
(Fittipaldi et al. 2012). 
 
Without phagocytosis, it is found with the phagocytes a mechanism of 
immune avoidance. Capsular sialic acid is considered as the factor that mediates this 
attachment. N-deacetylation of the peptidoglycan also reduces killing by 
neutrophils, probably by providing the bacterium with enhanced resistance against 
the action of lysozyme. The enhancement of resistance to host antimicrobial 
peptides and to resistance to neutrophil killing. S. suis through the contribution from 
D-alanylation of the LTA would bring out a cell wall-anchored DNase, which 
probably join NETs breakdown. The bacterium also secretes the serine protease 
SspA, capable of degrading IL-8, a major chemoattractant of neutrophils. It is 
believed that Secreted suilysin is toxic to phagocytes and also have the influence on 
complement activity. In order to resist the intracellular environment, SOD and the 
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arginine deiminase system can be applied by S. suis in the process of internalization 
(Fittipaldi et al. 2012). 
2.3.3. Inflammatory activation and septicemia 
Despite the fact that the activation of the immune system during microbial 
infection states protective, a consequence of excessive or poorly regulated immune 
response to the offending organism can be found as a septic shock (Tsiotou et al. 
2005).  Because human outbreaks of toxic shock-like syndrome and by septic shock 
cases caused by S. suis (in short incubation period, speedy disease development and 
a great mortal rate) have been found in Europe and Asia, it is suggested that 
proinflammatory mediators should be released in the time of S. suis systemic 
infections (Gottschalk et al. 2010). Therefore, a remarkable biological relevance can 
be connected to the ability of S. suis to induce cytokine production. The production 
of various proinflammatory cytokines by porcine, murine and human cells(Segura et 
al. 2002, Segura et al. 2002, Segura et al. 2004) is proved to be induced by S. suis 
serotype 2 virulent strains (Segura and Gottschalk 2002, Segura, Vadeboncoeur et 
al. 2002,Segura, Gottschalk et al. 2004) . It is said that the sudden early death of 
animals is caused by the high levels of systemic cytokines TNF-a, IL-6 and -12, 
IFN-g and the chemoattractants CCL2/MCP-1, CXCL1/KC, and CCL5/RANTES 
observed in vivo within 24 h postinfection.  
The regulatory cytokine IL-10 was upregulated following the onset of most 
proinflammatory cytokines, indicating a negative feedback mechanism to control 
the extent of the inflammatory response. S. suis-infected mice treated either with 
neutralizing antibodies against IL-10 or with recombinant IL-10 was revealed from 
the observations of changes in septic shock. These observations in mice can be seen 
as the development of the infection from swine pathogen and zoonotic agent to pigs 
and human and the exactly infected individuals can provide accurate inflammatory 
cytokines and chemokines level (Vanier et al. 2009, Ye et al. 2009).  
Cell receptor recognition probably comes from the Lipoproteins existence in 
the cell wall (Wichgers Schreur et al. 2010). A supposed prolipoprotein 
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diacylglyceryl transferase present in S. suis cell wall is essential for the innate 
immune activation (Segura et al. 2006, Graveline et al. 2007, Lecours et al. 2011, 
Wichgers Schreur et al. 2011). Suilysin was shown to activate phagocytes and to 
induce the release of proinflammatory cytokines (Lun et al. 2003, Segura et al. 
2006). In addition, suilysin might release hemoglobin from red blood cells, 
contributing to raise the levels of proinflammatory mediators by acting in synergy 
with S. suis cell wall components (Dominguez-Punaro et al. 2007). A surface-
associated subtilisin-like protease (SspA) has recently been shown to induce the 
secretion of different proinflammatory cytokines and chemokines by macrophages. 
Interestingly, a low concentration of SspA was associated with secretion of high 
amounts of CCL5, whereas the use of the same protein at high concentrations 
resulted in low amounts of CCL5 being detected, likely due to a proteolytic 
degradation of that chemokine by the same SspA (Figure 2) (Bonifait et al. 2011). 
Similar results had been observed by Vanier et al., who suggested that S. suis can 
induce an exacerbated release of inflammatory mediators resulting in massive 
recruitment of leukocytes and subsequent release of inflammatory mediators; 
however, S. suis may modulate this response, and improve its survival, by actively 
degrading the chemokines and thus delaying recruitment of neutrophils to the site of 
inflammation (Vanier et al. 2009). 
2.3.4. Central nervous system invasion and meningitis   
As other blood borne pathogens, S. suis must cross the blood-brain barrier 
(BBB) and/or the blood-cerebrospinal fluid (CSF)-barrier in order to cause central 
nervous system (CNS) infections. The BBB is an anatomically and functionally 
unique barrier that separates the brain from the intravascular compartment and 
maintains the homeostasis of the CNS environment (Rubin et al. 1999).  
The main cellular type of the BBB is brain microvascular endothelial cells 
(BMEC). Adhesion to, but not invasion of human BMEC has been demonstrated for 
S. suis (Charland et al. 2000). The join of the CPS is seen dissimilarly despite the 
fact that bacterial factors related to adhesion are not elucidated (Bonifait et al. 
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2010). In contrast, it has been demonstrated that pathogen is able to both attach and 
to invade immortalized porcine BMEC (Fig. 6), it is proved in antibiotic protection 
essays and electron microscopy. S. suis survived up to 7 h within porcine BMEC 
which can be considered as remarkable discovery because the main factor for the 
growth of meningitis is the capacity of pathogens to get through the BBB in the role 
of live bacteria (Vanier et al. 2004, Kim 2006). Benga et al. (2005) also showed 
internalization of S. suis when using the same cell line. However, this study did not 
consider the number of internalized bacteria to be significant and reported inability 
of S. suis to invade porcine BMEC (Benga et al. 2005). It might have different 
summaries because no general criteria have been found for the designation that if 
bacterial strains invasive or not on the base of the number of internalized bacteria. 
In fact, some researchers have arbitrarily defined a threshold to define the event as 
bacterial invasion (Benga et al. 2005). Vanier et al. (2007) also showed bacterial 
invasion of primary porcine BMEC (Vanier et al. 2007).  As suggested for epithelial 
cells, the CPS of S. suis partially interferes with the adhesion/ invasion abilities of 
the pathogen, perhaps because it hinders the display of putative adhesins (Fig. 6) 
(Vanier et al. 2004, Benga et al. 2005). Further characterization of the invasion 
process suggested the involvement of proteinaceous adhesins/ invasins and cell wall 
components such as the LTA (Vanier et al. 2007). Mutants impaired in LTA d-
alanylation adhered and invaded porcine BMEC to a significantly lesser extent than 
the wildtype strain (Fittipaldi et al. 2008). A S. suis SrtA mutant strain had reduced 
capacity to adhere and invade these cells, suggesting that LPXTG cell wall anchor 
proteins may also serve as adhesins/invasins (Vanier et al. 2008). Serum 
components may also participate in the interactions between S. suis and porcine 
BMECs (Vanier et al. 2004, Benga et al. 2005). Among them, only fibronectin was 
shown to play an important role (Vanier et al. 2007); in addition, antibodies against 
enolase (an important fibronectin-binding protein in S. suis) significantly decreased 
adhesion and invasion of porcine BMEC (Esgleas et al. 2008). Suilysin positive 
strains may also disrupt the BBB through cytotoxic effects, since at high bacterial 
doses suilysin-positive strains were toxic for porcine BMEC (Fig. 6). However, 
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suilysin was not indispensable for invasion, as a suilysin-negative mutant 
successfully invaded these cells (Vanier et al. 2004). 
The blood-CSF barrier CPECs might be another CNS entry portal for S. suis 
(Fig.6). The blood-CSF barrier still show its significant part in bacterial 
translocation as well as in leukocyte transmigration despite of its smaller surface 
area than the BBB. It has recently proved that there is the appearance of in vitro 
invasion and translocation of S. suis across the blood-CSF barrier (inverted trans 
well model) (Tenenbaum et al. 2009). This invasion was suggested to involve three 
potential steps: invasion of porcine CPEC from the basolateral side; transport within 
membrane-bound endocytic vacuoles to the apical side; and exocytosis onto the 
apical membrane of the blood-CSF barrier. S. suis adhered and invaded cells better 
when applied to basolateral membranes (Tenenbaum et al. 2009).  
 
 
Figure 6. Invasion of the central nervous system. 
 
Proteinaceous adhesins/invasins, and cell wall components such as the 
lipoteichoic acid (including lipoteichoic acid D-alanylation) have shown its 
connection to the invasion to and invasion of porcine BMEC. It is also necessary to 
consider the interaction with host extracellular matrix proteins (such as 
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fibronectin/fibrinogen). As suggested for epithelial cells, since the bacterial capsule 
partially interferes with the adhesion/invasion abilities of the pathogen; a possible 
down regulation of capsular polysaccharide expression has been suggested. LPXTG 
cell wall anchor proteins and enolase (through adhesion to fibronectin) may play a 
role as adhesins/invasins. Suilysin-positive strains may also disrupt the BBB 
through cytotoxic effects. Invasion and translocation of Streptococcus suis across 
the blood-CSF barrier has been shown. S. suis adhered better to porcine CPEC when 
applied to basolateral membranes, suggesting that direct access to the extracellular 
matrix was required. The capsular polysaccharide clearly compromised bacterial 
CPEC invasion, as demonstrated by the use of unencapsulated mutants, and 
indicating that bacterial cell wall components and/or surface proteins are needed. 
However, the nature of these adhesins/invasins remains largely unknown. S. suis is 
also able to affect the blood-CSF barrier function and integrity further facilitating 
trafficking of bacteria and leukocytes. It has been shown that S. suis induce CPEC 
necrosis, although apoptosis might also play a role in the process of cell death. 
Although other soluble factors might also be involved, suilysin plays an important 
role as a toxin affecting the blood-CSF barrier function (Fittipaldi et al. 2012). 
2.4. Epidemiology 
By the end of 2012, a total of 1,584 cases had been reported in the literature 
(including 189 probable cases identified in 3 outbreaks), mainly from Thailand 
(36%), Vietnam (30%), and China (22%). More than half (53%) were in the 
Western Pacific region; 36% were in the South East Asia region, 10.5% in the 
European region, and 0.5% in the Americas. The highest cumulative prevalence rate 
was in Thailand (8.21 cases/million population), followed by Vietnam (5.40) and 
the Netherlands (2.52) (country population data for 2008-2012 by World Bank). 
The pooled mean age of the patients was 51.4 years, and 76.6% were men. All case-
patients were adults, except 1 female infant reported in Thailand (Vilaichone et al. 
2002). The pooled proportion of case-patients with occupational exposure was 
38.1%; this proportion was higher for industrialized countries than for other 
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countries (83.8% for the United Kingdom, Netherlands, and Japan together) (Vu 
Thi Lan et al. 2014). Recent contact with pigs or pork was reported for 15.5% of 
single cases but for 33.9% in the meta-analysis. History of eating meals containing 
pork was reported mainly in Asia (Thailand and Vietnam); the pooled estimate was 
37.3% (95% CI 20.2%-58.3%). For Thailand only, the proportion was 55.8% (95% 
CI 33.7%-75.9%). In other countries, only 1 patient in France was reported eating 
artisanal dry sausage, and 1 patient in the United States ate raw pork while traveling 
in the Philippines before the infection. Skin injury was shown for one fourth of 
case-patients, and alcohol use was evident in approximately one third of case-
patients. However, a case-control study in Vietnam did not identify alcohol use as 
an independent risk factor after adjustment for other risk factors and confounders. 
The most commonly reported preexisting condition was diabetes. Other conditions 
included underlying heart disease, hypertension, cirrhosis, and cancer. Smoking was 
mentioned in 5.2% of patients in the single-case dataset. (Vu Thi Lan et al. 2014) 
2.5. Diagnosis and treatment of Streptococcus suis meningitis 
S. suis diagnosis is hampered by many bacteria caused purulent meningitis, 
which normally have similar clinical signs that make necessary the use of laboratory 
tools for rapid and specific detection. To diagnosis S. suis meningitis, CSF 
examination is the “gold standard” and mandatory. CSF culture is the standard 
procedure for diagnosis, and it is obligatory to obtain the in vitro susceptibility of 
the pathogenic bacteria and antibiotic treatment (van de Beek et al. 2006, Brouwer 
et al. 2010). Characteristic CSF findings for bacterial meningitis consist of 
polymorphonuclear pleocytosis, hypoglycorrhachia, and raised CSF protein level. 
CSF culture remains the gold standard for the diagnosis of bacterial meningitis. But 
sometimes, the yield of CSF culture is usually negative for patients who have 
received antibiotic pretreatment before lumbar puncture (van de Beek et al. 2006). 
In a study of McClelland et al. (2007),there were 103 patients with clinically 
defined meningococcal meningitis, only 13% had positive CSF cultures 
(McClelland et al. 2007). 
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The biochemical property allows S. suis classification on the basis of the 
metabolism of some molecules, such as esculine, trehalose, glycogen, lactose, 
saccharose…. Physiological and biochemical tests carried out on multiple serotype 
of S. suis with API 20 STREP, API 50CH and RAPID ID32STREP galleries 
(bioMérieux SA, Marcy l'Etoile, France), demonstrated a profile similar to that of 
entire S. suis serotypes. S. suis strains are postive in esculine, trehalose, glycogen, 
lactose, sacharose, starch, leucine aminopeptidase, alanine-phenyl-alanine-proline 
arylamidase tests, while most are noticeably negative in Voges-Proskauer, hipurate, 
ribose, arabinose and sorbitol tests. S. suis strains are in high percentage positive in 
arginine dihydrolase, β-glucoronidase, α-galactosidase, β-galactosidase, methyl-β-
dglucopyranoside, glycyl-tryptophan arylamidase and inulin tests. The major 
disadvantage of these methods is that they are time consuming (Chatellier et al. 
1998, Stanojković А. 2014). 
Latex agglutination is a diagnostic test that has been utilized for the 
etiological diagnosis of bacterial meningitis, providing results in less than 15 min. A 
ready-to-use chessboard system for Streptococcal group and serotyping of S. suis 
has been developed in form of latex particles coated with group specific 
streptococcal antiserum (A, B, C, D, F, G or L) or multiple serotype of S. suis 
antiserum raised in rabbits (0.0975 % sodium azide as preservation). The limitation 
of this method is intended for serotyping of pure cultures of capsulated 
Streptococcus sp. 
PCR assays have been evaluated for their effectiveness in detecting the 
presence of bacterial DNA in CSF from patients with suspected and proven 
bacterial meningitis. Many studies has focused in detecting the presence of 16S 
rRNA gene, glutamate dehydrogenase gene (gdh), polysaccharide capsular gene 
(cps) (Harris et al. 2003, Okwumabua et al. 2003, Marois et al. 2004, Bronska et al. 
2006, Nga et al. 2011, Wang et al. 2012, Kerdsin et al. 2014). Bronska et al. (2006) 
has used crgA and nested 16S rRNA primers were used to detect N. meningitidis, 
and siaD primers were used to identify serogroups B and C of N. meningitidis. 
There was 21 patients with meningococcal meningitis diagnosed either by culture or 
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by PCR, the data of this study showed positive CSF cultures for 9% of patients 
receiving  antibiotic pretreatment and 50% for those who did not (Bronska et al. 
2006). Marois et al. (2004) has developed a multiplex PCR assay for the detection 
of S. suis serotype 2 and ½ in specimen based on a the amplification of the gene 
coding for 16S rRNA and cps2J gene coding for the capsule of S. suis. The 
detection threshold of the test was 28 S. suis CFU/ml. The specificity and the 
sensitivity of the multiplex PCR test and the presence of an internal control allowed 
the analysis of biological samples without a culture step. (Marois et al. 2004). Nga 
et al. 2011 developed an internally controlled real-time PCR for detection of S. suis 
serotype 2 in CSF samples targeted at the cps2J gene (Nga et al. 2011) 
Antibiotics commonly used for the treatment of S. suis meningitis are 
penicillin G or ceftriaxone (Wertheim et al. 2009). In a large cohort of patients with 
S. suis meningitis, all strains were susceptible to penicillin, ceftriaxone, and 
vancomycin, but resistance to tetracycline (83%), erythromycin (20%), and 
chloramphenicol (3%) occurred (Mai et al. 2008). Resistance to cephalosporin has 
also been described and was related to genetic variation in the bacteria (Holden et 
al. 2009).  
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III. RESEARCH OBJECTIVES 
 
 
Main objective of this work is the development and evaluation of a specific 
and sensitive PCR assay for rapid and specific detection of Streptococcus suis 
serotype 2 based on the cps2J gene of S. suis for diagnosis hospitalized patients 
with meningitis.   
The second major objective is analysis of genetic relationship based on 
sequencing and phylogenic analysis of a fragment of rRNA genes, including the 
16S–23S rDNA ISR of S. suis serotype 2 isolated from human cases in central 
Vietnam. 
 The third major objective is identification and characterization of 
immunoreactive proteins of S. suis serotype 2 recognized by natural infection 
patient sera by immunoproteomics assay. 
 
  
Nguyen Hoang Bach - Molecular and antigenic characterization of Streptococcus suis serotype 2 isolates in 
central Vietnam - Doctorate Thesis of International PhD School In Biomolecular and Biotechnological 




VI. MATERIALS AND METHODOLOGIES 
 
4.1. Ethical approval 
The participants were explained about the research, its benefits and risk and 
asked to sign consent to participate. 
Study protocols were approved by Hue University of Medicine and Pharmacy 
Institutional Review Board.  
4.2. Media and buffers 
Nutrition Agar 
Peptic digest of animal tissue          5 g/L 
Sodium chloride                              5 g/L 
Beef extract                                  1.5 g/L 
Yeast extract                                 1.5 g/L 
Agar                                               15 g/L 
Water up to                                         1 L 
Final pH ( at 25°C) 7.4±0.2 
 
Blood Agar Base 
Beef heart peptone                         10 g/L 
Tryptose                                         10 g/L 
Sodium chloride                              5 g/L 
Agar                                               15 g/L 
Water up to                                          1L 
Final pH ( at 25°C) 7.3±0.2 
5% anti-coagulated Rabbit's blood  
 
Chocolate agar 
Heating after the blood has been added  
to the Blood Agar Base 
 
Brain-Heart Infusion broth  
Calf brain, infusion                      200 g/L 
Beef heart, infusion                     250 g/L 
SDS running buffer  
25 mM Tris 
0.192 M Glycine 
0.1%(w/v) SDS 
H2O MiliQ  to volume 
 
Transfer buffer 
25 mM Tris-HCl (pH 7.6)  
192 mM Glycine  
20% (v/v) Methanol  
H2O MiliQ  to volume 
 
PBS-T 
1X PBS buffer 
0.05% (v/v) Tween-20 




5%  (w/v) Skim milk 
H2O MiliQ  to volume 
 
Rehydration buffer 
6 M Urea 
2 M Thiourea 
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Proteose peptone                           10 g/L 
Disodium phosphate                     2.5 g/L 
Sodium chloride                              5 g/L 
Dextrose                                          2 g/L 
Final pH ( at 25°C) 7.4±0.2 
Water up to                                        1 L 
 
Lysic buffer 




1 M DTT* 
% SERVALYT™ Carrier 
Ampholytes pH 3-10  
Deionized water (Milli Q) 
 
SDS Equilibration buffer 
50 mM Tris-HCl pH 8.8  
6 M Urea 
30% (v/v) Glycerol 
2% (w/v) SDS 
H2O MiliQ  to volume 
 
Laemmli 1X Buffer , pH 6.8 
63 mM Tris HCl 
10% Glycerol 
5% (v/v) β- mercaptoethanol 
2% SDS 
0.0025% bromophenol blue 
H2O MiliQ  to volume 
 
 Trypsin working solution 
10µl of 100ng/µL trypsin in 0.01% 
TFA 
90 µl of 50 mM ABC  
4.3. Sampling  
Cerebrospinal fluid  
Forty cerebrospinal fluid (CSF) samples were collected between July 2013 - 
July 2014 by clinicians before antimicrobial therapy from hospitalized patient 
diagnosis of acute bacterial meningitis with clinical features: 
 General poor feeling 
 Sudden high fever 
 Severe, persistent headache 
 Neck stiffness 
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 Nausea or vomiting 
 Discomfort in bright lights 
 Drowsiness or difficulty awakening 
 Joint pain 
 Confusion or other mental changes 
Clinical specimens were transported to microbiological laboratory within 2 
hours after collection for microbiological analysis. CSF samples were processed for 
bacterial isolation immediately after arrival in laboratory. Also, aliquots of CSF 
samples were used for DNA extraction.  
Patient serum 
Collection of 3ml of venous blood of hospitalized patients after one week, two 
weeks and three weeks of the onset of infection was done in a serum vacuum blood 
collection tube (BD, New Jersey, USA). When the whole blood samples were 
transported to laboratory, the patient serum was separated as following steps:  
Allowing the blood to clot by leaving it undisturbed at room temperature in 30 
minutes. Removing the clot by centrifuging at 2,000 × g for 10 minutes at 4oC. 
Immediately transferring patient serum into the clean tubes. The patient serum will 
be was apportioned into 0.5 ml aliquots, stored at -80°C until use 
4.4. Bacterial strain, culture and isolation 
The CSF is purulent (very cloudy) was examined immediately without 
centrifugation. In all other cases, the CSF was centrifuged in a sterile tube at 10.000 
× g for 10 minutes. Removed the supernatant using a sterile Pasteur pipette fitted 
with a rubber bulb, and transferred it to another tube for chemical and/or serological 
tests. Used the sediment for further microbiological tests. 
 Sediment were cultured on blood agar base (BA)  and chocolate agar (CA) 
(HIMEDIA, Mumbai, India) at 37oC, 5% CO2 for 24 hour. Samples were also 
cultured in nutrition agar and brain-heart infusion broth (HIMEDIA, Mumbai, 
India) at 37oC for 24 hours. Identification of bacterial isolates was performed by 
standard procedures (Vandepitte et al. 2003).  
Nguyen Hoang Bach - Molecular and antigenic characterization of Streptococcus suis serotype 2 isolates in 
central Vietnam - Doctorate Thesis of International PhD School In Biomolecular and Biotechnological 




Briefly, S. suis was identified on basis of colony morphology, Gram stain 
and microscopic examination, and biochemical tests such as negative catalase 
reaction, optochin resistance, esculine hydrolysis, negativity for Voges-Proskauer 
test with API 20 Strep  ((BioMérieux SA, Marcy l'Etoile, France) (Tarradas et al. 
1994). 
4.5. DNA extraction 
The iVApDNA Extraction Kit (Viet A Technology Corporation, Ho Chi 
Minh City, Vietnam) was used for DNA extraction. Briefly, 100 μL of bacterial 
suspension or 200 μL CSF were treated as recommended by manufacturer. After the 
extraction procedure, DNA pellet was resuspended in a final volume of 50 μL in 
MiliQ water. Concentration and purity of total DNA were evaluated by using 
NanoDrop 2000 spectrophotometer (Thermo Scientific, Massachusetts, USA). DNA 
samples were stored at - 80oC until use. 
4.6. Capsular serotyping confirmation 
Real-time PCR assay was performed by using forward primer (5’-GGT TAC 
TTG CTA CTT TTG ATG GAA ATT-3’), reverse primer (5’-CGC ACC TCT TTT 
ATC TCT TCC AA-3’) and the TaqMan probe (5’ FAM-TCA AGA ATC TGA 
GCT GCA AAA GTG TCA AAT TGA-TAMRA 3’), which specifically target 85-
bp of the cps2J gene, a gene involved in the biosynthesis of serotype 2 specific S. 
suis polysaccharide capsule (Smith et al. 1999, Smith et al. 2000, Nga et al. 2011). 
10 ng DNA extractions from pure culture bacteria or 100 ng extractions from CSF 
samples, 0.4 µM for each primer, 0.1 µM of probe, 0.2 mM for each NTPs and 0.5 
units of Platinum®Taq DNA Polymerase (Invitrogen, Thermo Fisher Scientific, 
Massachusetts, USA) were combined in a 25 µL total volume reaction. PCR 
amplification was profiled as follows: initial denaturation at 95oC for 10 minutes, 
followed by 40 cycles of 95oC for 30 s, 55oC for 30 s, 72oC for 30 s in Mx3000P 
qPCR System (Agilent Technologies Inc., CA, USA): 
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Negative controls (no-template control) and other pathogenic bacteria (S. 
pneumoniae, N. meningitides, H. influenzae, S. suis serotype 1 were coupled to 
samples in each experiment for confirming specificity of primers and probe. A 
DNA sample extracted from the reference strain of S. suis serotype 2, provided by 
the Department of Microbiology, Hue Central Hospital, was used as positive 
control.  
PCR was considered positive if the negative controls were all negative and a 
FAM signal with a cycle threshold value (Ct) of ≤38 was obtained.  
4.7. 16S-23S rRNA intergenic spacer fragment amplication 
Pure culture DNA samples obtained from 18 S. suis serotype 2 isolates 
confirmed by real-time PCR were used for amplifying ITS fragments by traditional 
PCR. PCR analysis was accomplished using a newly designed forward primer (5’-
GCT GCA ACT CGC CTA CAT GA-3’) located at position 1259 of 16S rDNA and 
reverse primer (5’-ACT TAC AGC TCC CCA AGG CA-3’) located at position 93 
of 23S rDNA of Streptococcus suis 98HAH33 strain complete genome (Accession 
no. CP000408.1) by Geneious v8.1 software, which specifically amplify 
approximately a 729-bp amplicon including full length ITS fragment (Kearse et al. 
2012). 
100 ng genomic DNA, 0.4 µM for each primers, 0.2 mM for each dNTPs, 
0.5 units of Platinum®Taq DNA Polymerase (Invitrogen, Thermo Fisher Scientific 
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performed as follows: initial denaturation at 95oC for 10 min, followed by 36 cycles 
of 95oC for 30 s, 55oC for 30 s, 72oC for 30 s; then a final extension at 72oC for 5 
minutes in Veriti® Thermal Cycler (Applied Biosystems, CA, USA): 
 
PCR products were separated by electrophoresis on 1% agarose gel with 1X 
GelRedTM (Biotium Inc.) and digitalized with Essential V4 Gel Documentation 
(Uvitech Limited, Cambridge, UK). 
4.8. Gene profile analysis 
PCR products were purified using QIAquick PCR Purification Kit 
(QIAGEN, Hilden, Germany), following manufacturer instructions. Ten ng of 
purified ITS fragments and 0.32 µM of primer were used for direct sequencing. To 
sequence both strands, two specific PCR primers were run for each ITS sample. 
Chromatograms were analyzed with Geneious software v8.1 and compared with 
ITS sequence data strains available in the Genbank 
(http://www.ncbi.nlm.nih.gov/genbank/) by using the Blastn plugin of Geneious 
software (Kearse et al. 2012). All sequences were aligned using ClustalX (Larkin et 
al. 2007). The ITS sequences of S.suis serotype 2 from different countries (China, 
Taiwan, Germany, Denmark, France and Canada) were obtained from the GenBank 
for comparisons and construction of phylogenetic trees. Phylogenetic and molecular 
evolutionary analyses were performed using MEGA6 program. Phylogenies were 
reconstructed by using Maximum Likelihood method with bootstrap values 
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4.9. Whole protein extracts 
S. suis serotype 2 pellets were harvested in 10 ml BHI broth after 24 hours 
incubation by centrifuging at 8000 ×g/25oC in 10 minutes. Discarded completely 
the medium and washed 3 times with MiliQ water. Resuspended the pellets in 2% 
SDS (plus Tris-HCl pH 8.8) and vortex well. Incubated on a thermo-mixer in 10 
minutes at 99°C with agitation. Chilled the sample on ice and disruption and 
homogenization by using bead mill (TissueLyser LT, Qiagen, Hilden Germany ) in 
5 minutes, then sonicated in Digital Ultrasonic Unit T490 (ELMA, Singen, 
Germany). The remaining bacterial particles and non-lysed cells were removed and 
collected the supernatant by centrifugation at 8.000 × g/25oC in 10 minutes. The 
whole protein extracts were mixed with 1X Laemmli buffer then heated at 95oC in 5 
minutes for SDS-PAGE running or subjected to precipitation step for the 2-D 
electrophoresis. 
For the 2-D PAGE procedures, whole protein extracts were precipitated with 
2-D Clean-up Kit (GE Healthcare, Palo Alto, USA) following the manufacture 
instruction.  
4.10. SDS-PAGE 
5-15 µg of WPE extracted from SS2 were mixed in 1X Laemmli buffer. The 
samples were loaded in Mini-PROTEAN® TGX™ Precast Gels (Bio-Rad, CA, 
USA) and performed on a Protean Tetra Cell (Bio-Rad, CA, USA) at 50V in 15 
minutes (when the blue line reaches to the separating gel), 200V in 35 minutes (the 
blue line reaches to bottom of gel), following the manufacturer instructions. After 
run, gels were alternatively stained with SimplyBlue™ SafeStain (Life 
Technologies) then digitalized with the ImageScanner™ III (GE) or subjected to 
Western immunoblotting or band excisions step. 
4.11. Western immunoblotting  
SDS-PAGE resolved proteins with single reference 1 mm comb were 
transferred onto nitrocellulose membrane (Hybond-C Extra, Amersham, GE) with a 
Nguyen Hoang Bach - Molecular and antigenic characterization of Streptococcus suis serotype 2 isolates in 
central Vietnam - Doctorate Thesis of International PhD School In Biomolecular and Biotechnological 




Mini-Trans-Blot Cell (Bio-Rad, CA, USA) at 250 mA (100V) for one hour at 4°C. 
Checking the quality of protein transfer before Western blotting, membranes were 
incubated 50 ml of Ponseau solution (Sigma) in 5 minutes. Destaining Ponseau 
color with washing buffer. Then membranes were blocked with PBS-T containing 
5% (w/v) skim milk. For screening the patient serum, membranes were incubated 
for one hour with a patient serum 1:500 - 1:1500 dilutions in PBS-T containing 2% 
(w/v) skim milk in a Mini-PROTEAN II Multiscreen Apparatus (Bio-Rad, CA, 
USA). Membranes were washed five times for 5 minutes each with PBS-T and 
incubated with the Goat Anti-Human IgG-HRP-conjugated (Southern Biotech, 
Alabama, USA) as secondary antibodies diluted 1:50,000 in PBS-T containing 5% 
(w/v) skim milk in one hour. 
After five washes, membranes were developed with Luminata™ Forte 
Western HRP substrate (Merck Millipore Corp., Darmstadt, Germany) and images 
were acquired with a ChemiDoc™ XRS+ System and were analyzed by Image Lab 
Software (Bio-Rad, CA, USA).  
4.12. Pooled WPE againts pooled patient sera by western immunoblotting   
100 µg of a pool of whole protein extracts of 3 S. suis strains were used to 
perform the western immunoblotting followed the previous describes. SDS-PAGE 
resolved proteins were transferred onto Trans-Blot® Turbo™ Mini Nitrocellulose 
Transfer Packs  with Trans-Blot® Turbo™ Transfer System (2.5A, 25V, 7 minutes) 
(Bio-rad, CA, USA). Membranes were blocked with PBS-T containing 5% (w/v) 
skim milk and then were incubated for one hour with a pool of 2 patient sera with 
1:1500 dilutions in PBS-T containing 2% (w/v) skim milk. Membranes were 
incubated with the Anti-Human IgG (whole molecule)-Peroxidase antibody 
produced in goat (Sigma-Aldrich, Missouri, MO, USA) as secondary antibodies 
diluted 1:500,000 in PBS-T containing 5% (w/v) skim milk in one hour. 
The membranes were developed with Chemiluminescent Peroxidase 
Substrate-1(Sigma-Aldrich, Missouri, MO, USA) and images were acquired with 
the ImageScanner™ III (GE Healthcare, Palo Alto, CA, USA). 
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4.13. 2-D PAGE 
Prior  to  2-D  PAGE,  300 µg of whole protein extracts  were  resuspended  
in  rehydration buffer  with  1%  SERVALYT™ Carrier Ampholytes pH 3-10 
(SERVA Electrophoresis GmbH, Gemany). Passive rehydation the samples into 11 
cm SERVA IPG BlueStrips pH 3-10 NL (Serva Electrophoresis GmbH, CA, USA) 
in 6 hours. In order to improve the reproducibility and quality of 2-D gels by 
preventing streaking and to eliminate extra spots caused by non-specific oxidation 
of protein, 150 µl of DeStreak Rehydration Solution (GE Healthcare, Palo Alto, 
CA, USA) were supplied to the paper wick to cover the anode end of strips 
(Friedman et al. 2009). The strips were focused on Ettan IPGphor 3 system (GE 
Heathcare, Palo Alto, CA, USA) for 38,000 Vh with the following program: 
 
No step Volt Gradient Time 
1 250V Linear 3h 
2 500V Linear 2h 
3 1000V Linear 2h 
4 2500V Linear 1h 
5 5000V Linear 1h 
6 8000V Linaer 1h 
7 8000-20000V/h Step ‘n’ hold  
8 250V Linear 12h 
 
After focusing, strips were equilibrated in equilibrating buffer supplemented 
with 2% (w/v) dithiothreitol (DTT) for 15 min with agitation, and then with 2.5% 
(w/v) iodoacetamide (IAA) for 15 minutes with agitation. Washed the strips with 
1X Running buffer. The second dimension (SDS-PAGE) was conducted on Any 
kD™ Criterion™ TGX™ Gel, 11 cm IPG/prep+1 well, on Criterion™ Cell (Bio-
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rad, CA, USA) following manufacturer’s instructions. The running condition: 50V 
in 15 minutes, 100V in 15 minutes and 200V until the blue line reach the bottom of 
the gel. After the run, gels were alternatively stained with SimplyBlue™ SafeStain 
(Life Technologies, Grand Island, NY, USA) then digitalized with the 
ImageScanner™ III (GE) or subjected to spot picking.  
4.14. Band and spot excision and Coomassie-stained destaining  
The specific immunoreactive protein bands and spots obtained upon SDS-
PAGE, 2-D PAGE separation were matched through overlapping images of the blot 
and gel images. Desired protein band and spots were manually excised from gels: 
- Put the gels on the clean glass. 
- Excised spots by a 1 mm diameter micropipette tip (protein bands were 
excised by the clean scalpel). 
- Transferred gel pieces into a clean tube. 
- Shrink gel pieces by adding appropriately volume of acetonitrile (ACN) 
to cover completely the gel pieces and incubating for 30 minutes at RT. 
- Added 50mM ammonium bicarbonate (ABC) and incubated at RT for 10 
minutes, then shank with acetonitrile for 10 minutes. 
- Repeat sequentially until the gel pieces are completely destained.   
4.15. In-gel tryptic digestion and extraction of peptides digestion 
products  
Gel pieces were covered by 50 to 100 ng of trypsin depending on their 
intensity.  Put the gel pieces in a 2-8oC fridge for 60 minutes. Removed the excess 
of trypsin solution and added 50 mM ABC solution to completely cover the gel 
pieces. Gel pieces were then subjected to an O/N tryptic digestion at 37°C in 50 
mM ABC, pH 8.0.  
Chilled the tubes containing the gel pieces to room temperature. Spinned 
down and transfer the supernatant to a new tube. Added acetonitrile to completely 
cover the gel pieces and incubated for 10 minutes. Collected the supernatant by 
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centrifuging and repeated extracting the peptides from the ABC and ACN. Peptides 
were then acidified with TFA 20%, dried in SpeedVac® (Eppendorf, Hamburg, 
Germany), resuspended in 0.2% formic acid until mass spectrometry analysis or 
stored at -20°C. 
4.16.  LC-MS/MS ANALYSIS 
Peptide mixtures, obtained by spots and bands, were analyzed by LC-
MS/MS on a XCT Ultra 6340 ion trap equipped with a 1200 HPLC system and a 
chip cube (Agilent Technologies, Palo Alto, CA), as describe previously by Biosa et 
al. (2011)(Biosa et al. 2011). After loading, peptides were concentrated and desalted 
at 4 μL/min on a 40 nL enrichment column, with 0.2% formic acid and then 
fractionated on a C18 reverse-phase (75 μm×43 mm, Agilent Technologies Chip) at 
a flow rate of 300 nL/min, with a linear gradient of eluent B (0.2% formic acid in 
95% acetonitrile) in A (0.2% formic acid in 2% acetonitrile) from 3% to 60% in 20 
min. ESI parameters were as follows: Capillary voltage 1730 V; dry gas (N2), 5.00 
L/min; dry temperature, 325 °C; trap drive, 100; skimmer 30 V; lens 1, −5.00 V; 
octopole RF amplitude, 200 Vpp; capillary exit, 90 V. The ion trap mass 
spectrometer was operated in positive ion mode. 
Trap ICC smart target was 300,000 units and maximal accumulation time 
was 100 ms. MS/MS was operated at a fragmentation amplitude of 1.3 V, and 
threshold ABS was 6000 units. Scan speed was set in “standard-enhanced” mode at 
8100 (m/z)sec−1 for MS and “ultra scan” mode at 26,000 (m/z)sec−1 for MS/MS 
scans. Peptide analysis was performed scanning from m/z 250 to m/z 2200 in 
AutoMS (n) precursor selection mode of the three most intense ions (fragmentation 
mass range from 100 to 2200 m/z). Dynamic exclusion was used to acquire a more 
complete survey of the peptides by automatic recognition and temporary exclusion 
(0.15 min) of ions from which definitive mass spectral data had previously 
acquired.  
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4.17. Mass spectrophotometry data analyses 
Data Analysis software (6300 Series Ion Trap LCMS), provided by the 
manufacturer, was used to analyze raw MS and MS/MS spectra and to generate 
peak lists The peak list for each samples was analysed by Proteome Discoverer  
(version 1.4; Thermo Scientific, Bremen, Germany) using an in-house Mascot 
server (version 2.3; Matrix Science) for protein identification, according to the 
following criteria: database UniProtKB/Swiss-Prot (release 2015 05), enzyme: 
trypsin with two missed cleavages, taxonomy: Streptococcus, precursor mass 
tolerance 300 ppm, fragment mass tolerance 0.6 Da, methionine oxidation as 
dynamic and cysteine carbamidomethylation as static modification. The percolator 
algorithm was used for protein identifications in band and target-decoy peptide-
spectrum match (PSM) validator for protein identifications in spots.  
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V.  RESULTS 
 
5.1. Species identification 
Forty CSF samples were processed for bacterial isolation. A total of 36 
bacterial isolates were rescued and identified by culture-dependent methods. Four 
(10%) samples tested negative when seeded in cultures. Among bacterial isolates, 
18 (45%) were identified as S. suis by API®20 STREP with 85-90 % confidence 
while 2 (5%) were identified as S. pneumoniae. H. influenzae and N. meningitidis 
were detected in 6 (15 %) samples and L. monocytogenes was detected in 1 (2.5%). 
Nine (22.5%) isolates were identified as A. baumannii, E. coli, E. faecium, K. 
pneumoniae ss. pneumonia, Staphylococcus coagulase negative, and S. mitis. Co-
infections with two bacterial species were not detected. (Table 1).  
 
Table 1. Bacterial pathogens identified by culture-dependent methods from 
CSF samples 
Bacterial pathogens. No. of sample % 
Acinetobacter baumannii 2 5 
Escherichia coli 2 5 
Enterococcus faecium 1 2.5 
Klebsiella pneumoniae ss. pneumoniae 1 2.5 
Staphylococcus, coagulase negative 2 5 
Streptococcus mitis 1 2.5 
Haemophilus influenzae 3 7.5 
Listeria monocytogenes 1 2.5 
Neisseria meningitides 3 7.5 
Streptococcus pneumoniae 2 5 
Streptococcus suis 18 45 
Uncultured 4 10 
Total 40 100 
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5.2. Capsular serotype identification 
The real-time PCR assay for capsular serotype 2, all of 18 S. suis strains 
(45%) was positive (30-33 Ct value range on 3 replicates). Additionally, DNA 
extracted from CFS sample that was negative by isolation test was positive by real-
time PCR with a Ct value ranging from 33 to 37. All negative controls (non-
template controls, other bacterial pathogens such as S. pyogenes, S. pneumonia, S. 
aureus, Enterococcus, E. coli) were negative (Table 2). 
Table 2. Specificity of S. suis serotype 2 real-time PCR on culture-confirmed CSF 
samples and uncultured-confirmed samples. 






Acinetobacter baumannii 2 0 2 
Escherichia coli 2 0 2 
Enterococcus faecium 1 0 1 
Klebsiella pneumoniae ss. pneumoniae 1 0 1 
Staphylococcus, coagulase negative 2 0 2 
Streptococcus mitis 1 0 1 
Haemophilus influenza 3 0 3 
Listeria monocytogenes 1 0 1 
Neisseria meningitides 3 0 3 
Streptococcus pneumoniae 2 0 2 
Streptococcus suis 18 18 0 
Un-growth  4 1 3 
Total 40 19 21 
 
5.3. 16S-23S Intergenic spacer phylogenetic analysis 
Amplification of the 16S-23S intergenic spacer was confirmed by gel 
electrophoresis of the amplified fragments. The expected size of about 700bp was 
obtained (lanes 3-8) with all S. suis serotype 2 tested (Figure 1). 
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Figure 9. Amplification of ITS fragments of S. suis 2 by PCR. M: DL2000 DNA 
marker; lane 1: positive control; lane 2: negative control; lane 3 to 7 PCR products 
amplified from S. suis 2 strains 
 
A sequence including the full-length ITS region (about 455 bp) was obtained 
from each of the 18 amplicons of S. suis serotype 2. Alignments of 18 sequences 
allowed for their grouping into a single sequence type (100% pairwise identities). 
This sequence type was named HUE_286_2013 (GenBank accession number 
KR779926) and corresponds to nucleotides 327857-328585 of the complete genome 
of S. suis 98HAH33 (GenBank accession number CP000408).  
Alignment of HUE_286_2013 (KR779926) ITS with 13 16S-23S ribosomal 
RNA intergenic spacer sequences representative of S. suis and S. suis serotype 2 
(accession numbers EU860354, CP003736, AY585196, DQ204558, CP000407, 
AF489611, CP002651, CP000488, DQ204556, AY585199, AY585197, AY585194, 
AY585200) allowed the detection of high percentages of nucleotides identities 
among sequences, ranging from 98.1% (AY585200 ITS-SS/France/2004) to 
99.97% (DQ204558 ITS-SS2/Taiwan/2005). 
Maximum Likelihood trees based on the Kimura 2-parameter model obtained 
by aligning HUE_286_2013 ITS sequence with 23 Streptococcus species show that 
HUE_286_2013 clusters with S. suis together with S. parasanguinis in a 
monophyletic clade (Figure 2). 
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Figure 10. Molecular Phylogenetic analysis by Maximum Likelihood method based 
on the Kimura 2-parameter model of HUE_286_2013 and 23 Streptococcus species. 
 
Trees obtained with Maximum Parsimony and Maximum Likelihood and 
based on nucleotide alignment of sequence HUE_286_2013 with 13 sequences 
representative of S. suis serotype 2 and 1 S. parasanguinis sequence show that 
HUE_286_2013 strain clusters together with strains isolated worldwide; sequences 
AY585196 (SS2/France/2004), DQ20455B (SS2/Taiwan/2005), CP000407 
(SS2/China/2006), EU860354 (SS2/Denmark/2008) and CP003736 
(SS2/Canada/2012) (Figure 3). 
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Figure 11. Molecular Phylogenetic analysis of ITS sequences of S. suis serotype 2 
strains. A: Maximum Parsimony analysis of taxa. B: Maximum Likelihood method based 
on the Tamura 3-parameter model of S. suis serotype 2 strains. 
 
5.4. SDS-PAGE, western immunoblotting and immunogenic protein 
identification 
Whole protein extracts of S. suis serotype 2 isolates were analyzed by SDS-
PAGE following by western immunoblotting against pooled patient sera. As 
illustrated in Figure 12, a high number of bands were present in the total protein 




Figure 12: SDS-PAGE of whole protein extracts (WPE) from 3 S. suis serotype 
2 strains. MW: Precision Plus Protein™ All Blue Pre-stained Protein Standards; 






MW       1           2           3            4            5           6    
262                     286                    301    
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In order to investigate the reactivity of whole protein extracts with patient 
sera, whole protein extracts of each strain were performed the western 
immunoblotting in a Mini-PROTEAN II Multiscreen Apparatus (Bio-Rad, CA, 
USA). 11 patient sera were tested. The patient sera were collected at different times 
(after 1-3 week of infection) from 7 meningitis patients (infected with S. suis 
serotype 2 and N. meningitidis, H. influenza as negative sera). As illustrated in 
figure 13, based on immunoblotting results using positive and negative serum, we 
selected 2 patient sera: ID 286, 4 week serum; ID 301, 3 week serum which had 
more immunoreactive bands than the others.  
 
Figure 13: Western blot analysis of whole protein extracts of 3 S. suis isolates using 11 
sera from naturally infected patients. Lane 1: sera of patient ID 286 1 week; lane 2: sera 
of patient ID 286 4 week; lane 3: sera of patient ID 301 1 week; lane 4: sera of patient ID 
301 3 week. 
The separated and pooled aliquots of whole protein extracts of 3 strains (ID: 
262, 286, 301) were tested by western immunoblotting against pooled sera of 2 
selected patients. As illustrated in the figure 14, 5 immunoreactive bands were 
recognized by pooled patient sera with estimated molecular weights respectively of 
10, 29, 42, 52, and 60 kDa in both single and pooled lanes. 
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Figure 14: Pooled whole protein extracts against pooled patient sera in western blot 
analysis. A: SDS-PAGE of whole protein extracts; B: Ponseau staining; C: Western 
immunoblotting analysis. 1: WCA of 262 strain; 2: WCA of 286 strain; 3: WCA of 301 
strain; P: pool of protein of 3 strains. 
 
Five protein bands were detected and identified by LC-MS/MS on a XCT 
Ultra 6340 ion trap equipped with a 1200 HPLC system and a chip cube (Agilent 
Technologies, Palo Alto, CA, USA). 2 immunoreactive bands were identified as 
elongation factor Tu, enolase. Their identities, molecular weight (MW), 
identification score, number of peptide matches and sequence covered by the 
peptides are shown in Table 3. The sequence coverage ranged from 30 to 52% and 
the identification scores were from 107 to 1031. All proteins matched with 
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Table 3.  Identification of immunoreactive bands of 3 pooled S. suis serotype 2 isolates using sera from 2 naturally 
infected patients. 

















A A4VYQ3 50S ribosomal protein L14 
OS=Streptococcus suis (strain 98HAH33) 
GN=rplN PE=3 SV=1 - [RL14_STRS2] 
107.3
0 
37.70 9 6 6 6 122 13.0 10.27 
B A4VYP6 50S ribosomal protein L2 OS=Streptococcus 




50.54 11 14 14 20 277 29.8 10.70 
C A4VZZ3 Elongation factor Tu OS=Streptococcus suis 




52.26 15 21 21 40 398 44.0 4.98 
D A4W2T1 Enolase OS=Streptococcus suis (strain 




42.99 14 17 17 24 435 47.1 4.77 
E A4W4J9 Arginine--tRNA ligase OS=Streptococcus 




29.89 18 15 15 19 562 63.6 5.27 
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5.5. 2-D electrophoresis, western immunoblotting and immunogenic 
protein identification 
Whole protein extracts from isolates 262, 286 and 301 were pooled and 
resolved by 2-DE. Two-dimensional separation profile is shown for separation by 
isoelectric point (pI) on the first dimension using a pH ranges of 3-10 NL (Fig. 
15A). The separation profile was highly reproducible in 2-DE followed by Western 
blot analysis with pooled serum from infected patients as stated in 4.12 material and 
methodology section (Fig. 15B). 
As shown in figure 15.B, there are 5 immunoreactive spots recognized by the 
pooled patient sera with estimated molecular weight respectively 36, 46, 48, 52 and 
67 kDa. 5 protein spots were detected and identified by LC-MS/MS on a XCT Ultra 
6340 ion trap equipped with a 1200 HPLC system and a chip cube (Agilent 
Technologies, Palo Alto, CA). 4 out of five immunoreactive spots were respect 
identified as: elongation factor Tu, enolase, 60 kDa chaperonin, chaperone protein 
DnaK. Their identities, molecular weight (MW), identification score, number of 
peptide matches and sequence covered by the peptides are shown in Table 4. 
Sequence coverage ranged from 27 to 39% and the identification scores were from 
463 to 758. Four proteins matched with Streptococcus suis strain 98HAH33. There 
is one protein that matched with 60 kDa chaperonin of Streptococcus anginosus 
having the equivalent pI, WM with S. suis 60 kDa chaperonin.  
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Figure 15. 2-DE proteome map (130 mm IPG strip, pH 3–10) and immunoblot 
analysis of WPE protein from pooled of 3 strains. A. Preparative gel stained with 
coomassie blue compatible MS. Molecular weight markers are on the left in kilodalton. B. 
Another gel run in parallel was used for immunoblot analysis (all sera were diluted 
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We estimated the MW and pI values of the protein spots on 2-D gels, and 
then compared them to the theoretical MW and pI values. There are some 
discrepancies between the experimental MW and theoretical MW values, while the 
experimental pI values are consisting with the theoretical ones (in range from pH 4 
to pH 5). These discrepancies may be caused by posttranslational proteolytic 
processing and modifications, and by cleavage of alkaline regions and 
phosphorylation of multiple residues (Jing et al. 2008) 
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Table 4.  Identification of immunoreactive spots of 3 pooled S. suis serotype 2 isolates using sera from 2 naturally 
infected patients. 

















5 A4VZB5 Chaperone protein DnaK 
OS=Streptococcus suis (strain 
98HAH33) GN=dnaK PE=3 SV=1 - 
[DNAK_STRS2] 
596.39 28.34 20 18 18 22 607 64.8 4.75 
4 Q8KJ20 60 kDa chaperonin 
OS=Streptococcus anginosus 
GN=groL PE=3 SV=1 - 
[CH60_STRAP] 
758.17 30.74 13 3 16 24 540 56.9 4.73 
3 A4W2T1 Enolase OS=Streptococcus suis 
(strain 98HAH33) GN=eno PE=3 
SV=1 - [ENO_STRS2] 
526.26 26.90 14 11 11 16 435 47.1 4.77 
2 A4VZZ3 Elongation factor Tu 
OS=Streptococcus suis (strain 
98HAH33) GN=tuf PE=3 SV=2 - 
[EFTU_STRS2] 
463.06 38.94 15 14 14 22 398 44.0 4.98 
1 A4W2T1 Enolase OS=Streptococcus suis 
(strain 98HAH33) GN=eno PE=3 
SV=1 - [ENO_STRS2] 
78.69 5.98 16 2 2 2 435 47.1 4.77 
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The most common cause of bacterial meningitis in neonates and infants is 
Streptococcus agalactiae (group B streptococci), followed in order of frequency by 
E. coli, other gram-negatives, and L. monocytogenes. (Greenlee 2007). Recently, S. 
suis infection has become the most common cause of meningitis in adults in 
Vietnam and in other Asian Countries such as China (including Hong Kong) and 
Thailand. In Thailand S. suis infection was mostly reported in the Northern 
provinces. Between 2006-2012, 38 patients with S. suis infection were hospitalized 
In Nakhon Phanom. Deafness developed in 12 patients and none died (Praphasiri et 
al. 2015). In China, a large outbreak of S. suis serotype 2 (SS2) emerged in summer 
2005 in Sichuan with 38 fatalities and 215 infected people (Huang et al. 2005). S. 
suis serotype 2 was also reported to cause sporadic illness in human in various 
European Countries (France, Germany, Denmark, United Kingdom, Netherlands), 
in Australia, and in the United States (Wisselink et al. 2000, Tarradas et al. 2001, 
Rosenkranz et al. 2003, Lee et al. 2008, Tramontana et al. 2008).  In Vietnam, S. 
suis serotype 2 infection is the most common cause of meningitis in adults. 
Approximately 40% of all acute bacterial meningitis cases in adults in Ho Chi Minh 
City and in Hanoi were attributed to S. suis serotype 2 infection (Nghia et al. 2008, 
Health 2011, Nga et al. 2011, Nghia et al. 2011).  
Results obtained in this study showed that S. suis serotype 2 was detected in 
47.5% (19 positive of 40 CSF samples) of all meningitis cases. Although it can be 
postulated that in Vietnam S. suis serotype 2 infection frequency can be higher. 
Indeed only a few local laboratories are able to confirm S. suis serotype 2 infection 
by PCR and this cause the pathogen to be overlooked and underdiagnosed. A great 
proportion of human infected by S. suis serotype 2 was found to be associated with 
the individual habit of farming domestic animals at home, in which pigs are raised 
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in closed small piggery with unhygienic condition and slaughtered without 
quarantine work, this resulting in contamination of raw pork products (Nghia et al. 
2008, Nga et al. 2011, Nghia et al. 2011). Moreover, the unsafe habit of purchasing 
pork in flea markets and consumption of undercooked animal products is a well-
established risk factor for acquiring many infectious diseases, especially S. suis 
serotype 2 from pig (Hoa et al. 2011, Huong et al. 2014). A recent study from Hong 
Kong reported heavy contamination of S. suis in raw pork meat at local 
supermarkets or wet markets; therefore, hot and humid climates may facilitate the 
growth of S. suis in raw pork products (Cheung et al. 2008). 
We detected one CSF positive for S suis serotype 2 by real-time PCR in 4 
CSF samples which were negative by bacterial isolation. CSF was significantly 
more often negative in culture in patients who received antimicrobial treatment 
before hospitalization. Real-time PCR might be a more sensitive and reliable 
method for S. suis serotype 2 detection and early diagnosis in clinical samples (Nga 
et al. 2011). 
Amplification and sequencing resulted in the same product size of the 18 ITS 
sequences obtained in this study (455 bp). Gel electrophoresis of the 18 amplified 
ITS constantly revealed only 1 band, and sequence data were compatible with the 
presence of a single template. Surprisingly ITS sequences of the 18 isolates 
obtained in this study showed 100% homology when aligned although strains were 
isolated from 18 CSF of 18 patients with meningitis at different time of 
hospitalization, and infected subjects were from different districts in the Thua Thien 
Hue province. Isolates of S. suis serotype 2 in Thua Thien Hue could be under a 
constant selection pressure resulting in stability of ITS gene sequences, as also 
suggested by the lack of a spacer region (Marois et al. 2006) in the isolates 
sequenced in this study.  
The combination of 2-D PAGE, immunoblotting and mass spectrometric 
analysis is an effective approach for identity immunoreactive proteins, and to 
development of vaccine, diagnostic tools and therapy molecule. This strategy has 
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been used for some bacteria such as Mycoplasma mycoides,  Streptococcus 
pneumoniae, Streptococcus equi ssp. Zooepidemicus, Bordetella bronchiseptica, 
Vibrio parahaemolyticus, Brucella melitensis (Mao et al. 2011, Yang et al. 2011, 
Corona et al. 2013, Li et al. 2014, Liu et al. 2014, Olaya-Abril et al. 2014). 
Multifunctional glycolytic enzymes (such as glyceraldehyde-3-phosphate 
ehydrogenase and a-enolase), which generally localize in the cytoplasm, were found 
to be exported to the cell surface of a variety of microorganisms by an unknown 
mechanism (Pancholi 2001, Feng et al. 2009).  
In our study, we found 4 antigenic proteins recognized by natural infection 
patient sera based on immunoproteomics approach. These are enolase,  60kDA 
chaperonin, Chaperone protein DnaK and elongation factor Tu. These proteins have 
been identified by LC-MS/MS and they matched with Streptococcus suis serotype 
2, 98HAH33 strain. All of these proteins have been confirmed to have 
immunogenicity with different host immune system in recent reports. Enolase has 
been developed as a novel model vaccine against S. suis and S. sorbrinus infection 
in mice (Dinis et al. 2009, Feng et al. 2009, Zhang et al. 2009). 
Enolase, an enzyme responsible for the dehydration of 2-phosphoglycerate 
(2-PGE) to phosphoenolpyruvate (PEP), was recognized recently as a plasminogen-
binding protein, endowing this pathogen with host proteolytic activity, as an 
immunodominant antigen involved in the virulence of Streptococcus species. 
Enolase is a multifunctional protein, and it could serve as a plasminogen receptor on 
the surface of a variety of hematopoetic, epithelial and endothelial cells suggests 
that it may play an important role in the intravascular and pericellular fibrinolytic 
system. In addition to this property, its ability to function as a heat-shock protein 
and to bind cytoskeletal and chromatin structures indicate that enolase may play a 
crucial role in transcription and a variety of pathophysiological processes. (Pancholi 
2001, Kolberg et al. 2006, Esgleas et al. 2008, Dinis et al. 2009). Kolberg et al. 
2006 produced mAb 245,C-6 (IgG1) in a BALB/c mouse after immunizing with a 
protein fraction from S. pneumoniae. The mAb reacted with recombinant 
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pneumococcal enolase both under non-denaturing and denaturing conditions 
(Kolberg et al. 2006). Dinis et al. (2009) in efforts toward the development of an 
effective and safe vaccine against dental caries caused by Streptococcus sobrinus  
have directed to use of recombinant enolase in rats. It showed the association 
between oral therapeutic vaccination with recombinant enolase  increase in 
resistance to S. sobrinus colonization and increased levels of salivary IgA and IgG 
against this protein in rats (Dinis et al. 2009). In our study, spot 1 was matched to 
SS2 enolase. SS2 enolase were recognized by patient sera after 1-3 week infection 
in both 1-D and 2-D gel western immunoblotting. Feng et al 2009, Lu et al 2012 
had identified the enolase gene from SS2 and systematically characterized its 
protein product, enolase. In consideration of the strong antigenicity of enolase, an 
efficient enolase-based method was established for monitoring SS2 infections. 
Combined evidence strongly indicated that SS2 enolase can localize on the bacterial 
cell surface and facilitate bacterial adherence. Additionally, these studies show that 
enolase can confer complete protection against SS2 infection to mice, which 
suggests that enolase has potential as a vaccine candidate.(Feng et al. 2009, Lu et al. 
2012) 
 60kDA chaperonin (variously known as Cpn60, HSP60 or GroEL) presents  
in almost serotype  of  S. suis,  and was shown to be secreted in to the culture 
supernatant and, to lesser extent, cell-associated (Benkirane et al. 1997). 60kDA 
chaperonin belongs to stress proteins or heat-shock proteins family (hsps). It can be 
found in a variety of microorganism including Gram-negative and positive bacteria, 
yeast. Spot 4 was matched to SS2 60KDa chaperonin. In recent years, hsps have 
been recognized as potent immunogens in a number of infections and have been 
related to the survival of bacteria in the host, or to the pathogenesis of the bacteria. 
In the study of Cainelli Gebara et al. (2007), the soluble fraction obtained from 
Bordetella pertussis was evaluated as adjuvant for the pertussis component of the 
Diphtheria-Pertussis-Tetanus (DPT) vaccine. High levels of antibodies were 
induced, and a 78% protection rate of mice challenged with live B. pertussis was 
observed. Two proteins were identified as the 73 kDa N-terminal alpha-domain of 
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BrkA autotransporter protein and the Cpn60/60 kDa chaperonin. Both stimulated 
antibodies against pertussis and induced a 42% protection rate against the challenge 
(Cainelli Gebara et al. 2007). Phillips et al. (2013) used sera from individuals 
colonized with Neisseria meningitidis and from patients with meningococcal 
disease contain antibodies specific for the neisserial heat-shock/chaperonin (Chp)60 
protein. Immunization of mice with recombinant (r)Chp60 induced high and similar 
levels of antibodies that recognized Chp60 in outer membranes (Phillips et al. 
2013). Our studies show that 60kDA chaperonin, as a potent immunogen, has been 
recognized by patients sera with meningococcal disease containing antibodies by 
western immunoblotting. 
Chaperone protein DnaK is a member of the heat-shock proteins family. It 
has been identified as prominent antigen in the immune response to a wide variety 
of infections. These proteins are highly conserved at the genetic level and are 
generally thought to play a critical role in protein folding, protein-protein 
interactions (in the assembly and disassembly of protein complexes), and protein 
translocation across membranes, in reversing polypeptide unfolding and preventing 
protein aggregation, as well as in repairing proteins that have been damaged or 
misfolded by stress (Krska et al. 1993, Young et al. 1993, Vanghele M 2010).  In 
our study, spot 5 matched with SS2 Chaperone protein DnaK. Molecular chaperone 
DnaK operon proteins include HrcA, GrpE, DnaK, and DnaJ. A recent study of 
Chen et al. (2011) reported that DnaK might be involved in the adhesion of SS2 to 
HEp-2 cells (Chen et al. 2011, Zhang et al. 2015). Takaya et al. (2004) found that 
the DnaK/DnaJ chaperone machinery is required by Salmonella enterica serovar 
Typhimurium for invasion of epithelial cells and survival within macrophages and 
is essential for causing a systemic infection in the host (Takaya et al. 2004). It also 
was identified as secreted protein by proteomic analysis in SS2 (Zhang et al. 2007). 
DnaK might be a good vaccine candidate, as reported in S. pneumoniae (Hamel et 
al. 1997), Mycobacterium tuberculosis (Lowrie et al. 1997), and SS2 (Zhang et al. 
2007).  
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Translation elongation factors are responsible for two main processes during 
protein synthesis on the ribosome. Elongation factor-Tu (EF-Tu) mediates the entry 
of the aminoacyl tRNA into a free site of the ribosome. Spot 2 was matched to SS2 
EF-Tu. EF-Tu was identified as immunogenic protein in Bacillus cereus group 
(Delvecchio et al. 2006) and SS2 (Zhang et al. 2007, Zhang et al. 2008). 
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This study confirms the importance of S. suis serotype 2 as a prominent 
bacterium causing purulent meningitis in adults in Vietnam. Real-time PCR may 
represent a sensitive method for detection of S. suis serotype 2. Local isolates are 
genetically stable and this could promote the development of specific molecular 
assays for diagnosis.   
We identify antigenic proteins of S. suis serotype 2 in human. Three strains 
of S. suis serotype 2, 262, 286 and 301, were studied. Using different sera from S. 
suis naturally infected patients, we found 4 immunoreactive proteins which may 
represent strain-specific antigenic proteins and potential protective antigens: 
enolase, 60kDA chaperonin, chaperone protein DnaK, elongation factor Tu. These 
proteins have been confirmed to have immunogenicity with different host immune 
system in recent reports. Future studies will conducted to validate the antigen and to 
develop the recombinant-ELISA test in order to investigate sensitivity and 
specificity of these recombinant antigens when tested with sera obtained from 
naturally infected patient. 
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Fig. Chromatogram of spot no. 3 generated XCT Ultra 6340 ion trap equipped 




Fig. Compound spectra of spot no. 3 generated XCT Ultra 6340 ion trap equipped 
with a 1200 HPLC system and chip cube (Agilent Technologies, Palo Alto, CA) 
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